Terms: = Bone cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Prognosis
320 results:
1. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
[TBL] [Abstract] [Full Text] [Related]
2. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
[TBL] [Abstract] [Full Text] [Related]
3. Necroptosis-related lncRNA-based novel signature to predict the prognosis and immune landscape in soft tissue sarcomas.
Long Q; Li Z; Yang W; Huang K; Du G
J Cancer Res Clin Oncol; 2024 Apr; 150(4):203. PubMed ID: 38635069
[TBL] [Abstract] [Full Text] [Related]
4. Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect.
Murdock HM; Ho VT; Garcia JS
Front Immunol; 2024; 15():1359113. PubMed ID: 38571944
[TBL] [Abstract] [Full Text] [Related]
5. Combined set7/9 and CDK4 inhibition act synergistically against osteosarcoma.
Shi Y; Wang Z; Shao Y; Guang Q; Zhang J; Liu B; Wu C; Wang Y; Sui P
Biochem Biophys Res Commun; 2024 May; 708():149808. PubMed ID: 38520914
[TBL] [Abstract] [Full Text] [Related]
6. Construction of an oxidative phosphorylation-related gene signature for predicting prognosis and identifying immune infiltration in osteosarcoma.
Zhou P; Zhang J; Feng J; Wang G
Aging (Albany NY); 2024 Mar; 16(6):5311-5335. PubMed ID: 38506898
[TBL] [Abstract] [Full Text] [Related]
7. Construction of a predictive model for bone metastasis from first primary lung adenocarcinoma within 3 cm based on machine learning algorithm: a retrospective study.
Zhang Y; Xiao L; LYu L; Zhang L
PeerJ; 2024; 12():e17098. PubMed ID: 38495760
[TBL] [Abstract] [Full Text] [Related]
8. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
[TBL] [Abstract] [Full Text] [Related]
9. Exploring risk factors and molecular targets in leukemia patients with COVID-19: a bioinformatics analysis of differential gene expression.
Ullah MA; Moin AT; Nipa JF; Islam NN; Johora FT; Chowdhury RH; Islam S
J Leukoc Biol; 2024 Mar; 115(4):723-737. PubMed ID: 38323674
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism.
Cai F; Liu L; Bo Y; Yan W; Tao X; Peng Y; Zhang Z; Liao Q; Yi Y
BMC Cancer; 2024 Feb; 24(1):166. PubMed ID: 38308235
[TBL] [Abstract] [Full Text] [Related]
11. Role of PAX6, TRPA1, BCL11B, MCOLN2, CUX1, EMX1 in colorectal cancer and osteosarcoma.
Zhang J; Gao Q; Hou S; Chi X; Zheng M; Zhang Q; Shan H; Zhang X; Kang C
Medicine (Baltimore); 2024 Feb; 103(5):e37056. PubMed ID: 38306561
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic marker CXCL5 in glioblastoma polyformis and its mechanism of immune invasion.
Yu W; Zhou M; Niu H; Li J; Li Q; Xu X; Liang F; Rui C
BMC Cancer; 2024 Jan; 24(1):140. PubMed ID: 38287266
[TBL] [Abstract] [Full Text] [Related]
13. Nε-(1-Carboxymethyl)-L-lysine/RAGE Signaling Drives Metastasis and cancer Stemness through ERK/NFκB axis in Osteosarcoma.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Int J Biol Sci; 2024; 20(3):880-896. PubMed ID: 38250151
[TBL] [Abstract] [Full Text] [Related]
14. Development and validation of neutrophil extracellular traps-derived signature to predict the prognosis for osteosarcoma patients.
Lin Y; Tang H; Teng H; Feng W; Li F; Liu S; Liu Y; Wei Q
Int Immunopharmacol; 2024 Jan; 127():111364. PubMed ID: 38101221
[TBL] [Abstract] [Full Text] [Related]
15. Association of WHSC1/NSD2 and T-cell infiltration with prostate cancer metastasis and prognosis.
Li Q; Zhu J; Zhang Y; Pan Y; Li Z; Wang M; Gao Y; Feng D; He X; Zhang C
Sci Rep; 2023 Dec; 13(1):21629. PubMed ID: 38062230
[TBL] [Abstract] [Full Text] [Related]
16. Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon.
Li H; Lin G; Cui M; Wang L; Ding D; Li X; Fan X; Yang Q; Wang Y; Kang C; Zhang L; Liu B; Su J
Medicine (Baltimore); 2023 Dec; 102(48):e36414. PubMed ID: 38050320
[TBL] [Abstract] [Full Text] [Related]
17. Daratumumab for patients with myeloma with early or late relapse after initial therapy: subgroup analysis of CASTOR and POLLUX.
Spencer A; Moreau P; Mateos MV; Goldschmidt H; Suzuki K; Levin MD; Sonneveld P; Orlowski RZ; Yoon SS; Usmani SZ; Weisel K; Reece D; Ahmadi T; Pei H; Mayo WG; Gai X; Carey J; Bartlett JB; Carson R; Dimopoulos MA
Blood Adv; 2024 Jan; 8(2):388-398. PubMed ID: 38048391
[TBL] [Abstract] [Full Text] [Related]
18. Construction and validation of a novel NAD
Yu R; Lu G; Cheng B; Li J; Jiang Q; Lan X
J Orthop Res; 2024 May; 42(5):1086-1103. PubMed ID: 38047487
[TBL] [Abstract] [Full Text] [Related]
19. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma.
Hong X; Fu R
PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294
[TBL] [Abstract] [Full Text] [Related]
20. A novel prognostic classification integrating lipid metabolism and immune co-related genes in acute myeloid leukemia.
Li D; Wu X; Cheng C; Liang J; Liang Y; Li H; Guo X; Li R; Zhang W; Song W
Front Immunol; 2023; 14():1290968. PubMed ID: 38022627
[TBL] [Abstract] [Full Text] [Related]
[Next]